Prev Arrow Stocks

Clorox Company (The) ($CLX) Stock Forecast: Up 5.1% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is Clorox Company (The)?

A consumer goods company, Clorox Co. (CLX), known for its household cleaning products, showed strength in the stock market today, surpassing its competitors.

Why is Clorox Company (The) going up?

CLX stock is up 5.1% on Jun 5, 2026 17:47

  • Clorox Co. stock price rose by 1.24% to $89.63, performing better than its rivals amidst a robust trading session.
  • The upward trend is possibly linked to a new partnership with Arxada to introduce Quanticare™ technology in Clorox Healthcare HyperOxi Disinfecting Wipes, offering innovative solutions for healthcare facilities.
  • Investors seem optimistic about the potential growth in demand for Clorox products in healthcare sectors, particularly in the fight against hospital-acquired infections.
  • The stock's positive momentum may also be influenced by the overall market upswing, as the S&P 500 Index increased by 0.41% and the Dow Jones Industrial Average by 1.73%, creating a favorable trading climate for Clorox Co.

CLX Price Chart

CLX Technical Analysis

CLX News

A Look At Oil-Dri Corporation of America’s (ODC) Valuation After Recent Share Price Strength

Oil-Dri Corporation of America (ODC) has seen significant share price strength recently, with its stock up 73.54% year-to-date and 428.71% over five years. Despite this momentum, the stock is trading at $84.08, which is only slightly below its estimated intrinsic value of $85.47 according to Simply Wall St's Discounted Cash Flow model, suggesting it isn't deeply discounted. However, its Price-to-Earnings ratio of 24.2x makes it appear overvalued compared to its direct peers (17.6x) and the broader Global Household Products industry (16.5x), indicating investors are paying a premium for its profitability.

https://simplywall.st/stocks/us/household/nyse-odc/oil-dri-corporation-of-america/news/a-look-at-oil-dri-corporation-of-americas-odc-valuation-afte

0 News Article Image A Look At Oil-Dri Corporation of America’s (ODC) Valuation After Recent Share Price Strength

Church & Dwight Co Inc stock (US1713401024): NYSE price moves lower as investors eye consumer staple

Church & Dwight Co Inc (US1713401024) stock traded lower on the NYSE on June 3, 2026, reflecting broader volatility in the US consumer products sector. The stock closed at USD 92.89, down 3.38%, amidst investor reassessment of defensive names in a changing interest-rate environment. The company, known for brands like Arm & Hammer, operates in a consumer staples sector characterized by steady but modest growth, competing with larger players while navigating cost inflation and evolving consumer preferences.

https://www.ad-hoc-news.de/boerse/news/ueberblick/church-and-dwight-co-inc-stock-us1713401024-nyse-price-moves-lower-as/69484867

1 News Article Image Church & Dwight Co Inc stock (US1713401024): NYSE price moves lower as investors eye consumer staple

Clorox Co. stock outperforms competitors on strong trading day

Shares of Clorox Co. (CLX) advanced 1.24% to $89.63 on Thursday, a day when the broader stock market saw gains. The S&P 500 Index rose 0.41% and the Dow Jones Industrial Average increased by 1.73%. Despite the positive movement, Clorox Co. remains 32.11% below its 52-week high.

https://www.marketwatch.com/data-news/clorox-co-stock-outperforms-competitors-on-strong-trading-day-a41dec00-431681529448?mod=mw_quote_news

2 News Article Image Clorox Co. stock outperforms competitors on strong trading day

Arxada Announces Strategic Agreement with Clorox Healthcare to Launch Quanticare(TM) Technology in Clorox Healthcare HyperOxi Disinfecting Wipes, a Breakthrough Sporicidal Disinfectant for Healthcare Facilities

Arxada has announced a strategic, long-term agreement with Clorox Healthcare to introduce its Quanticare™ hard-surface disinfectant technology to healthcare facilities across North America, starting with Clorox Healthcare HyperOxi Disinfecting Wipes. This bleach-free, EPA-registered sporicidal technology effectively kills C. difficile spores in four minutes and other key pathogens in one minute or less, aiming to significantly reduce hospital-acquired infections. The collaboration marks a major step in providing innovative disinfection solutions for healthcare professionals.

https://finance.yahoo.com/sectors/healthcare/articles/arxada-announces-strategic-agreement-clorox-120000664.html

3 News Article Image Arxada Announces Strategic Agreement with Clorox Healthcare to Launch Quanticare(TM) Technology in Clorox Healthcare HyperOxi Disinfecting Wipes, a Breakthrough Sporicidal Disinfectant for Healthcare Facilities

Arxada & Clorox Advance Healthcare Disinfection

Arxada has announced a strategic agreement with Clorox Healthcare to launch its Quanticare™ hard-surface disinfectant technology in Clorox Healthcare HyperOxi Disinfecting Wipes. This partnership introduces a revolutionary bleach-free sporicidal technology to healthcare facilities across North America, capable of killing C. difficile spores in four minutes and other pathogens in one minute or less. The EPA-registered solution is designed to help front-line healthcare professionals combat hospital-acquired infections effectively and safely.

https://www.accessnewswire.com/newsroom/en/chemicals/arxada-announces-strategic-agreement-with-clorox-healthcare-to-launch-quanticaretm-techno-1172685

4 Missing News Article Image Arxada & Clorox Advance Healthcare Disinfection

Clorox Company (The) Price History

01.04.2026 - CLX Stock was down 7.8%

  • Reductions in price targets by UBS and other firms, attributed to weaker fiscal 2026 guidance and sales challenges, likely played a role in the bearish movement.
  • Factors such as Clorox's lowered earnings forecast, transaction costs from acquisitions, and declining demand for cleaning products are impacting investor sentiment and driving the stock price down.
  • Challenges in gross margin, litter, and food segments, coupled with increased costs and consumer spending selectivity, are further pressuring Clorox's stock performance.
  • Despite some areas of strength, negative outlook and concerns expressed by analysts and the company's management have outweighed positive aspects, contributing to the bearish market movement.

01.04.2026 - CLX Stock was down 9.3%

  • Clorox witnessed a notable decline in its shares following the disclosure of the company's fiscal third-quarter results and a revised FY26 forecast, highlighting ongoing difficulties for the organization.
  • The reduced profit outlook is linked to decreases in the Lifestyle segment, escalating manufacturing and logistics costs, and expenses tied to the GOJO acquisition, all of which are impacting the company's margins and overall profitability.
  • Analysts from UBS, Goldman Sachs, Morgan Stanley, and Evercore ISI have all adjusted their price targets for Clorox downwards, expressing worries about the weaker guidance, sales hurdles, and margin challenges.
  • While certain sectors such as cleaning, international operations, and professional services demonstrate robust performance, issues in gross margin, litter, and food segments, coupled with the updated fiscal year projection, have contributed to the negative market trend for Clorox shares.

21.10.2025 - CLX Stock was up 5.0%

  • The positive market sentiment towards consumer goods companies likely contributed to CLX's upward movement.
  • Competitors' emphasis on premium, high-performance products, such as PG, could have indirectly influenced investors' trust in CLX's product range.
  • Investor optimism about CLX's potential to leverage consumer conservatism for increased margins and customer loyalty could be driving the company's positive outlook.

17.01.2026 - CLX Stock was down 3.6%

  • The bearish movement in Clorox's stock today may be linked to the recent slight decline in Q2 sales and net income. This is happening alongside the company's continuation of its dividend streak and reaffirmation of full-year earnings guidance.
  • Investor concerns regarding Clorox's ability to maintain its transformation amidst challenges such as sluggish category growth and consumers seeking lower-priced options could be influencing the market reaction.
  • The introduction of a waterless version of Tide detergent by a competitor may also be impacting Clorox's stock. This new product showcases innovation in the consumer goods industry and could potentially overshadow Clorox's own initiatives.
  • Furthermore, the recent executive stock sales at a competitor following a mixed earnings report might be signaling caution among investors in the consumer goods sector. This cautious sentiment is contributing to a broader negative outlook affecting Clorox's stock price.

29.04.2026 - CLX Stock was down 5.2%

  • Clorox (CLX) experienced a bearish movement today, possibly due to the sudden resignation of CEO Linda Rendle for health reasons.
  • The uncertainty surrounding the leadership transition and the impact it may have on the company's long-term strategic plans could be causing investor concern.
  • Investors are likely monitoring how the new CEO will navigate challenges such as cost savings, competition, and innovation in the face of recent financial guidance cuts.
  • The market's reaction to the CEO's departure suggests a need for clarity and confidence in Clorox's future direction to regain investor trust and stabilize the stock price.

29.04.2026 - CLX Stock was down 5.6%

  • Clorox (CLX) stock dropped 3.6% today.
  • CEO Linda Rendle's resignation due to health reasons has raised concerns among investors about the company's future strategy and performance.
  • The company's decreased 2026 earnings guidance, higher debt levels from acquisitions, and analyst price target reductions have contributed to negative investor sentiment.
  • Investors are monitoring the impact of the leadership change on cost efficiencies, innovation, and overall performance, amid competitive pressures and market uncertainty.

05.05.2026 - CLX Stock was up 5.1%

  • Clorox Co. stock price rose by 1.24% to $89.63, performing better than its rivals amidst a robust trading session.
  • The upward trend is possibly linked to a new partnership with Arxada to introduce Quanticare™ technology in Clorox Healthcare HyperOxi Disinfecting Wipes, offering innovative solutions for healthcare facilities.
  • Investors seem optimistic about the potential growth in demand for Clorox products in healthcare sectors, particularly in the fight against hospital-acquired infections.
  • The stock's positive momentum may also be influenced by the overall market upswing, as the S&P 500 Index increased by 0.41% and the Dow Jones Industrial Average by 1.73%, creating a favorable trading climate for Clorox Co.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.